Literature DB >> 8998397

The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.

M Pitkänen1, J Sirviö, E MacDonald, S Niemi, T Ekonsalo, P Riekkinen.   

Abstract

The present study was undertaken to investigate the effects of modulation of the N-methyl-D-aspartate (NMDA) receptor on learning and memory. Thus, the performance of rats treated with D-cycloserine, a partial agonist at the glycine recognition site of the NMDA receptor complex, and MK-801, a noncompetitive NMDA receptor antagonist, either alone or concurrently were assessed in radial arm maze and water maze tasks. Administration of MK-801 (0.1 mg/kg, i.p.) impaired acquisition in the water maze (increased escape latency and distance) and working memory in the radial arm maze (increased re-entries) in rats. Moreover, in the radial arm maze, MK-801 disrupted locomotion (increased latencies and decreased arm entries per minute) and impaired the acquisition of reference memory (increased number of errors) performance of rats. D-Cycloserine (0.03, 0.3, 1.0, 3.0, 10 mg/kg, i.p.) had no effects on acquisition or memory performance of control or MK-801-treated rats in either of these tasks. However, D-cycloserine (0.03, 0.3, 3.0 mg/kg) reversed the MK-801-induced disruption in locomotion. Furthermore, 3.0 mg/kg D-cycloserine increased behavioral activity and also decreased the time needed to complete the task in control animals. To conclude, our results suggest that the consequences of NMDA receptor modulation on learning and memory processes and sensorimotor functions may be functionally different or have distinct anatomical locations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8998397

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  13 in total

1.  The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder.

Authors:  Noa Albelda; Nitza Bar-On; Daphna Joel
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

2.  Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq.

Authors:  Stefanie Malan-Müller; Lorren Fairbairn; Willie M U Daniels; Mahjoubeh Jalali Sefid Dashti; Edward J Oakeley; Marc Altorfer; Martin Kidd; Soraya Seedat; Junaid Gamieldien; Sîan Megan Joanna Hemmings
Journal:  Metab Brain Dis       Date:  2015-09-23       Impact factor: 3.584

3.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

4.  D-cycloserine 24 and 48 hours after asphyxial cardiac arrest has no effect on hippocampal CA1 neuropathology.

Authors:  Vélvá M Combs; Heather D Crispell; Kelly L Drew
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-06       Impact factor: 6.200

5.  Previous stress attenuates the susceptibility to Midazolam's disruptive effect on fear memory reconsolidation: influence of pre-reactivation D-cycloserine administration.

Authors:  Silvia Gabriela Bustos; Marcelo Giachero; Héctor Maldonado; Víctor Alejandro Molina
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

6.  Impairment of the anterior thalamic head direction cell network following administration of the NMDA antagonist MK-801.

Authors:  Adam A Housh; Laura E Berkowitz; Isaac Ybarra; Esther U Kim; Brian R Lee; Jeffrey L Calton
Journal:  Brain Res Bull       Date:  2014-10-13       Impact factor: 4.077

7.  Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial.

Authors:  Hsien-Yuan Lane; Cheng-Hao Tu; Wei-Che Lin; Chieh-Hsin Lin
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

Review 8.  Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition.

Authors:  Trevor W Robbins; Emily R Murphy
Journal:  Trends Pharmacol Sci       Date:  2006-02-21       Impact factor: 14.819

9.  Deletion of Glycogen Synthase Kinase-3β in D2 Receptor-Positive Neurons Ameliorates Cognitive Impairment via NMDA Receptor-Dependent Synaptic Plasticity.

Authors:  Yan-Chun Li; Priyalakshmi Panikker; Bo Xing; Sha-Sha Yang; Cassandra Alexandropoulos; Erin P McEachern; Rita Akumuo; Elise Zhao; Yelena Gulchina; Mikhail V Pletnikov; Nikhil M Urs; Marc G Caron; Felice Elefant; Wen-Jun Gao
Journal:  Biol Psychiatry       Date:  2019-11-06       Impact factor: 13.382

10.  D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats.

Authors:  Marta Portero-Tresserra; Paula Cristóbal-Narváez; Margarita Martí-Nicolovius; Gemma Guillazo-Blanch; Anna Vale-Martínez
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.